Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 0 · FY2024 0
Georgian pharmaceutical wholesale/distribution company. Limited public information available beyond the Reportal filing.
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Margins | |||||||
| Gross Margin | 45.7% | 40.9% | 50.2% | 51.6% | 51.9% | 53.9% | 54.2% |
| EBITDA Margin | 25.6% | 5.0% | 19.2% | 23.4% | 30.5% | 26.3% | 31.1% |
| EBITDAR | 2,673 | 1,264 | 6,631 | 9,834 | 18,487 | 15,264 | 24,750 |
| EBITDAR Margin | 25.6% | 5.0% | 19.2% | 23.4% | 30.5% | 26.3% | 31.1% |
| EBIT Margin | 25.6% | 5.0% | 19.2% | 23.4% | 30.4% | 26.1% | 30.7% |
| Net Profit Margin | 25.4% | 5.8% | 22.5% | 25.7% | 23.6% | 29.6% | 31.7% |
| Operating Expense % of Sales | 20.1% | 35.9% | 31.1% | 28.2% | 21.4% | 27.6% | 23.0% |
| Returns | |||||||
| Return on Assets (ROA) | 29.6% | 7.7% | 27.5% | 20.4% | 28.7% | 25.4% | 27.9% |
| Return on Equity (ROE) | 95.6% | 34.5% | 64.7% | 51.7% | 40.6% | 32.8% | 32.5% |
| ROIC [EBIT / Invested Capital] | 163.4% | 48.8% | 69.7% | N/A | 118.3% | 32.3% | 45.6% |
| Leverage & debt balances | |||||||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 31.0% | 22.3% | 42.5% | 39.6% | 70.7% | 77.6% | 85.8% |
| Net Debt | -1,140 | -1,649 | -2,518 | -24,393 | -19,587 | -5,403 | -23,869 |
| Cash & Equivalents | 1,140 | 1,649 | 2,518 | 24,393 | 19,587 | 5,403 | 23,869 |
| Total Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Liquidity & working capital | |||||||
| Current Ratio | 1.45x | 0.89x | 1.34x | 1.34x | 2.16x | 1.91x | 4.16x |
| Quick Ratio | 1.42x | 0.86x | 1.34x | 1.15x | 2.11x | 1.38x | 3.53x |
| Cash Ratio | 0.18x | 0.11x | 0.15x | 0.76x | 1.34x | 0.36x | 1.86x |
| Total Current Assets | 8,940 | 13,052 | 21,803 | 42,707 | 31,448 | 28,913 | 53,482 |
| Total Current Liabilities | 6,179 | 14,742 | 16,250 | 31,896 | 14,590 | 15,129 | 12,852 |
| Inventory | 174 | 380 | 82 | 6,122 | 688 | 8,106 | 8,087 |
| Trade Receivables | 7,555 | 10,930 | 17,736 | 11,345 | 7,589 | 8,504 | 14,610 |
| Trade Payables | 6,097 | 14,286 | 16,250 | 31,824 | 14,134 | 14,948 | 12,773 |
| Net Working Capital | 2,761 | -1,690 | 5,553 | 10,811 | 16,858 | 13,784 | 40,630 |
| Net Working Capital % of Revenue | 26.4% | -6.7% | 16.0% | 25.7% | 27.8% | 23.8% | 51.1% |
| Trade Working Capital | 1,632 | -2,976 | 1,568 | -14,356 | -5,857 | 1,662 | 9,924 |
| Trade Working Capital % of Revenue | 15.6% | -11.8% | 4.5% | -34.2% | -9.7% | 2.9% | 12.5% |
| Change in Trade Working Capital | N/A | -4,608 | 4,544 | -15,925 | 8,499 | 7,519 | 8,262 |
| Turnover & efficiency | |||||||
| Inventory Turnover | 32.54x | 39.29x | 210.03x | 3.32x | 42.39x | 3.30x | 4.51x |
| Days Inventory Outstanding (DIO) | 11.2 | 9.3 | 1.7 | 110.1 | 8.6 | 110.7 | 81.0 |
| Receivables Turnover | 1.38x | 2.31x | 1.95x | 3.70x | 7.99x | 6.82x | 5.44x |
| Days Sales Outstanding (DSO) | 264.1 | 157.9 | 187.0 | 98.6 | 45.7 | 53.5 | 67.1 |
| Payables Turnover | 0.93x | 1.04x | 1.06x | 0.64x | 2.06x | 1.79x | 2.85x |
| Days Payable Outstanding (DPO) | 392.1 | 349.4 | 344.3 | 572.2 | 176.9 | 204.1 | 127.9 |
| Cash Conversion Cycle | -116.8 days | -182.2 days | -155.5 days | -363.5 days | -122.6 days | -39.9 days | 20.1 days |
| Asset Turnover | 1.17x | 1.33x | 1.22x | 0.80x | 1.22x | 0.86x | 0.88x |
| Cash flow & dividends | |||||||
| Operating Cash Flow | 968 | 6,076 | 756 | 28,232 | 9,472 | 5,029 | 18,253 |
| Free Cash Flow (OCF − Capex proxy) | 953 | 166 | 765 | 22,737 | -824 | -13,729 | 17,898 |
| Cash Conversion (OCF / EBITDA) | 36.2% | 480.6% | 11.4% | 287.1% | 51.2% | 32.9% | 73.7% |
| Dividends Declared | 0 | 0 | 0 | 1,934 | 0 | 0 | 0 |
| Dividend Payout Ratio | 0.0% | 0.0% | 0.0% | 17.9% | 0.0% | 0.0% | 0.0% |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →